Warning: The NCBI web site requires JavaScript to function. more...
Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
López E, Guerrero R, Núñez MI, del Moral R, Villalobos M, Martínez-Galán J, Valenzuela MT, Muñoz-Gámez JA, Oliver FJ, Martín-Oliva D, Ruiz de Almodóvar JM.
Breast Cancer Res. 2005;7(5):R690-8. Epub 2005 Jul 1.
Related citations
Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
Pinar B, Lara PC, Lloret M, Bordón E, Núñez MI, Villalobos M, Guerrero R, Luna JD, Ruiz de Almodóvar JM.
Radiat Res. 2007 Oct;168(4):415-22.
Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy.
Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, Thielmann HW, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Bartsch H, Chang-Claude J.
Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1216-25.
Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients.
Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA.
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1173-9.
Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z, Nemeskéri C, Fekésházy A, Sáfrány G, Bajzik G, Nagy ZP, Bidlek M, Sinkovics I, Udvarhelyi N, Liszkay G, Repa I, Galuska L, Trón L, Mayer A, Esik O.
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1022-33.
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
Henríquez-Hernández LA, Carmona-Vigo R, Pinar B, Bordón E, Lloret M, Núñez MI, Rodríguez-Gallego C, Lara PC.
Radiat Oncol. 2011 Jun 6;6:60.
Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J, Neubauer S, Becker A, Gebhart E.
Strahlenther Onkol. 1998 Oct;174(10):510-6.
Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.
Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J, Peters LJ.
Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1371-9.
Normal tissue radiosensitivity in breast cancer patients.
Ramsay J, Birrell G.
Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):339-44.
Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D.
Radiother Oncol. 2000 May;55(2):179-86.
Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients.
Kiltie AE, Barber JB, Swindell R, Ryan AJ, West CM, Hendry JH, Magee B.
Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):481-7.
Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):489-95. Epub 2005 Oct 24.
Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity.
Ruiz de Almodóvar JM, Guirado D, Isabel Núñez M, López E, Guerrero R, Valenzuela MT, Villalobos M, del Moral R.
Radiother Oncol. 2002 Mar;62(3):327-33.
Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy.
Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J.
Radiother Oncol. 2003 Nov;69(2):145-53.
In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients.
Oppitz U, Schulte S, Stopper H, Baier K, Müller M, Wulf J, Schakowski R, Flentje M.
Int J Radiat Biol. 2002 Jul;78(7):611-6.
Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K, Hoeller U, Nowack S, Bernhard M, Röper B, Brackrock S, Petersen C, Szymczak S, Ziegler A, Feyer P, Alberti W, Dikomey E.
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):256-64.
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.
Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH.
Radiother Oncol. 1994 Dec;33(3):228-38.
Comparison of the radiosensitivity of normal-tissue cells with normal-tissue reactions after radiotherapy.
Slonina D, Klimek M, Szpytma T, Gasinska A.
Int J Radiat Biol. 2000 Sep;76(9):1255-64.
[Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J, Gebhart E, Neubauer S.
Strahlenther Onkol. 1995 Oct;171(10):581-6. German.
Breast cancer acute radiotherapy morbidity evaluated by different scoring systems.
López E, Núñez MI, Guerrero MR, del Moral R, de Dios Luna J, del Mar Rodríguez M, Valenzuela MT, Villalobos M, Ruiz de Almodóvar JM.
Breast Cancer Res Treat. 2002 May;73(2):127-34.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on